TNGX
Tango Therapeutics Inc
24.50$
-4.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.0% | +0.9% | -6.1% | -7.6% | -10.2% | -13.3% | -13.3% | -11.7% | +89.7% | +9.3% | +146.4% | |
| – | -6.6% | +1.6% | -6.7% | -8.4% | -11.5% | -15.5% | -15.5% | -13.8% | +116.0% | +10.9% | +163.0% | |
| – | +13.4% | -7.9% | -15.7% | +3.1% | +30.8% | -16.0% | -32.8% | +48.5% | +92.5% | +40.6% | +118.9% | |
| – | -6.4% | +2.0% | -6.3% | -9.0% | -12.1% | -16.0% | -16.6% | -15.5% | +124.6% | +10.7% | +167.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.4% | -5.1% | -5.6% | -7.9% | -5.1% | -8.1% | -4.3% | -51.3% | +4.8% | -15.7% | +11.4% | |
| – | +5.8% | -6.9% | +2.5% | -14.3% | +1.6% | -5.9% | +11.4% | -53.9% | +17.5% | -33.9% | +41.7% | |
| – | +2.1% | -0.8% | +14.4% | +21.1% | -14.3% | +15.1% | -10.3% | +22.4% | -11.7% | +3.4% | +3.9% | |
| – | -1.8% | +40.0% | -72.8% | +287.2% | -61.1% | +102.3% | -19.5% | -14.5% | -47.0% | +105.6% | -25.5% | |
| – | -8.5% | +4.5% | -6.3% | -7.5% | -12.9% | -16.4% | -19.1% | +18.6% | +116.3% | +13.1% | +161.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.3% | +12.9% | +0.1% | +0.2% | +0.2% | +1.5% | +0.2% | +0.4% | +4.7% | +23.6% | +4.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.